Skip to Main Content

Browse issues

Volume 11, Issue 3, March 2024

Review Articles

Bradley J Langford and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae053, https://doi.org/10.1093/ofid/ofae053

With the rapid advancement of artificial intelligence, the field of infectious diseases faces both innovation and disruption. We provide considerations for infectious diseases specialists to leverage this growing technology while mitigating its risks.

Reagan K Barfield and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofad687, https://doi.org/10.1093/ofid/ofad687

The top 13 publications of 2022 describing an actionable antimicrobial stewardship intervention were selected by a modified Delphi technique. This summary will serve as a resource for readers seeking to stay up to date on successful antimicrobial stewardship strategies.

Cybele Lara R Abad and Raymund R Razonable
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae036, https://doi.org/10.1093/ofid/ofae036

Endemic mycoses may cause severe disease among SOT recipients, especially those with epidemiologic risk. Fever, disseminated disease, and cytopenia are common. Heightened suspicion for these mycoses is needed to facilitate early recognition and reduce morbidity and mortality rates in SOT recipients.

Jo-Anne H Young and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae082, https://doi.org/10.1093/ofid/ofae082

The Sankey approach provides a dynamic visual model to understand the changing risk of invasive aspergillosis from diagnosis of an underlying condition throughout the treatment journey. Future upgrades could include actionable links to references or bundles of pharmacologic or non-pharmacologic interventions.

Rose I Okonkwo and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofad670, https://doi.org/10.1093/ofid/ofad670

Behavioral and Social Aspects of Infectious Diseases

Major Article

Karen B Vanterpool and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae015, https://doi.org/10.1093/ofid/ofae015

Kidney, liver, heart, and lung transplant recipients who acquired hepatitis C from donor organs described positive experiences overall; however, some had concerns about hepatitis C transmission, treatment costs, and unexpected treatment delays, highlighting opportunities for improved education.

Clinical Trials and Therapeutics

Major Articles

Bhavani Perumal Kannabiran and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae034, https://doi.org/10.1093/ofid/ofae034

Our randomized clinical trial compared safety and efficacy of high-dose rifampicin (R25/R35) against conventional dose (R10). We found that R35 was more toxic than R10. R25 was equally safe and more efficacious than R10; hence, it may be implemented for treatment shortening of drug-susceptible pulmonary tuberculosis.

Jorge Calderón-Parra and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae121, https://doi.org/10.1093/ofid/ofae121

In this prospective multicenter cohort with 4,548 infective endocarditis cases, mycotic aneurysms (MA) developed in 2%, with half being intracranial. Rupture was common, correlating with poor prognosis. A notable portion of initially intact intracranial MA ruptured within the initial days.

Adishesh K Narahari and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae064, https://doi.org/10.1093/ofid/ofae064

The NIH disbursed more than $4 billion in funding to large consortiums and clinical trials to develop diagnostics, therapeutics, and vaccines. Approximately 8% of funding was used for R01 grants. Clinical trial sites were generally located in areas of high COVID-19 burden.

Namareq F Aldardeer and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae059, https://doi.org/10.1093/ofid/ofae059

This study investigated the timing of β-lactam antibiotic dose adjustment in sepsis patients with acute kidney injury. The findings indicated that delaying antipseudomonal β-lactam antibiotic dose adjustment was associated with reduced in-hospital mortality.

Cynthia L Gay and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofad694, https://doi.org/10.1093/ofid/ofad694

One of 4 participants administered anti-PD-1 antibody exhibited increased HIV-1specific T-cell responses and transiently increased HIV-1 expression. Significant immune-related adverse events after a single, low dose of anti-PD-1 antibody may limit translating the benefits of anti-PD-1 therapies from cancer to HIV.

Lara E Coelho and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae035, https://doi.org/10.1093/ofid/ofae035

Integrase strand transfer inhibitor–based antiretroviral therapy (ART) did not increase the risk of tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) in the Reflate TB2 randomized controlled trial. Low CD4 counts and high HIV-RNA at ART initiation and extrapulmonary/disseminated TB were risk factors for TB-IRIS.

Frederik Schaltz-Buchholzer and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae057, https://doi.org/10.1093/ofid/ofae057

In a randomized controlled trial from Guinea-Bissau contrasting BCG-Japan and BCG-Russia, BCG strain was not associated with differences in all-cause morbidity and mortality by 6 weeks or 6 months of age. BCG-Japan produced more and larger BCG skin reactions.

Brief Report

Amber C Streifel and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae070, https://doi.org/10.1093/ofid/ofae070

Diagnostic Methods and Tools

Major Articles

Andrej Spec and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae010, https://doi.org/10.1093/ofid/ofae010

Itraconazole is the mainstay therapy for endemic mycoses. Unfavorable pharmacokinetics lead to subtherapeutic levels and adverse effects. Super-bioavailability itraconazole is bioequivalent to conventional itraconazole, with similar clinical outcomes, but has fewer adverse events, possibly owing to lower drug-level variability.

James H Hart and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae096, https://doi.org/10.1093/ofid/ofae096

We describe a novel population of urgent care clinic patients diagnosed and treated for community-acquired pneumonia. Variability in the use of chest imaging among patients diagnosed with pneumonia reveals opportunities for improving clinical decision-making support and antibiotic stewardship. Existing tools for predicting pneumonia severity which are based on ED and inpatient data overestimated the need for hospital admission.

Satoshi Hayano and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae026, https://doi.org/10.1093/ofid/ofae026
Laurel Joncas-Schronce and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae084, https://doi.org/10.1093/ofid/ofae084

Brief Report

Rusheng Chew and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae071, https://doi.org/10.1093/ofid/ofae071

Education and Training in Infectious Diseases

Brief Report

Jasmine R Marcelin and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae116, https://doi.org/10.1093/ofid/ofae116

Epidemiology and Disease Surveillance

Major Articles

John J Ross and Kevin L Ard
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae091, https://doi.org/10.1093/ofid/ofae091

Septic arthritis of the facet joint is a distinct clinical syndrome typically involving the lumbar spine, and frequently associated with bacteremia, posterior epidural abscesses, and paraspinal pyomyositis. Neurologic outcomes are usually good with medical management alone.

Diya M Uthappa and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae081, https://doi.org/10.1093/ofid/ofae081

In a college population, an index-cluster sampling strategy in which clusters were established based on geographic proximity alone did not enrich for cases of respiratory viral transmission.

Katharina Kusejko and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae055, https://doi.org/10.1093/ofid/ofae055
Brittney M Snyder and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae077, https://doi.org/10.1093/ofid/ofae077

Timely identification of infants at highest risk of respiratory syncytial virus–related morbidity is key to prevention. We developed a personalized risk prediction tool using birth/postnatal data that may have applications in promoting immunoprophylaxis to prevent the most severe infant respiratory syncytial virus infections.

Frederikke Kristensen Lomholt and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae069, https://doi.org/10.1093/ofid/ofae069
Juan P Aguilar Ticona and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae065, https://doi.org/10.1093/ofid/ofae065

We found a high level of transmissibility of the SARS-CoV-2 BA.1* Omicron variant both within the community and households. Phylogenetic analysis suggests a diverse set of viruses were transmitted within the community and households, consistent with multiple introductions and high rates of incidence.

Agus Rachmat and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae062, https://doi.org/10.1093/ofid/ofae062
Claire Nour Abou Chakra and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae085, https://doi.org/10.1093/ofid/ofae085

A systematic review (93 studies) and meta-analysis were conducted to assess the association between bacterial strains and complications, recurrence, and mortality in Clostridioides difficile infection. NAP1/BI/R027 was associated with unfavorable outcomes. Data on other strains were insufficient for significant conclusions.

Brief Reports

Ting-Yi Chen and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae008, https://doi.org/10.1093/ofid/ofae008
Jeremy A W Gold and Kaitlin Benedict
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae117, https://doi.org/10.1093/ofid/ofae117
Patrick Musole Bugeme and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae058, https://doi.org/10.1093/ofid/ofae058

Global Health and Infectious Diseases

Major Articles

Phyu M Latt and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae011, https://doi.org/10.1093/ofid/ofae011
Rebecca A Abelman and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae033, https://doi.org/10.1093/ofid/ofae033
Margaret Lartey and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae061, https://doi.org/10.1093/ofid/ofae061

Over half of adults with HIV initiated on a dolutegravir-based regimen developed hypertension, with a quarter of them developing it 6 months post–dolutegravir initiation. Incidence was higher in treatment-naive persons. Obesity and low high-density lipoprotein were risk factors for developing hypertension.

Laura Chen and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae045, https://doi.org/10.1093/ofid/ofae045

We identified 2 genetic polymorphisms associated with greatly increased risk of astrovirus diarrheal infections in the first year of life, the A allele of rs75437404 (odds ratio, 2.71) and the C allele of rs75935441 (odds ratio, 4.17).

Levanco K Asia and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae111, https://doi.org/10.1093/ofid/ofae111

In South African people with HIV, the presence of Vpr amino acid G41 showed significant associations with higher levels of soluble urokinase plasminogen activator receptor compared to other amino acids at these positions.

Simiso Sokhela and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae007, https://doi.org/10.1093/ofid/ofae007

Dolutegravir combined with tenofovir alafenamide or tenofovir disoproxil fumarate had high potency and safety, with no resistance to dolutegravir after 192 weeks, but it sustained weight gain, especially among women, those with low initiation CD4 counts, and those taking tenofovir alafenamide.

ID Public Health and Health Policy

Major Articles

Jessica Stewart and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae056, https://doi.org/10.1093/ofid/ofae056
Ahuva Averin and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae097, https://doi.org/10.1093/ofid/ofae097

Study findings indicate that acute-care costs for lower respiratory tract illness due to respiratory syncytial virus (RSV-LRTI) are high among US adults, and that attributable costs for RSV-LRTI remain high throughout the 1-year period following the acute phase of illness.

Infectious Diseases in Special Populations

Major Articles

Ahmed Babiker and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae060, https://doi.org/10.1093/ofid/ofae060

In a retrospective study of 3,507 renal transplant recipients (RTRs) the detection of an MDRO during the early post-transplant (EPT) period was associated with death-censored allograft loss. This suggests the need for increased strategies to optimize prevention of MDROs colonization and infection.

Brian Conway and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofad638, https://doi.org/10.1093/ofid/ofad638
Ricardo Rabagliati and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae052, https://doi.org/10.1093/ofid/ofae052

There are scarce epidemiologic data on febrile neutropenia infections in people with hematologic malignancies in Latin America. This retrospective and multicenter study offers updated knowledge regarding bloodstream infections, predominantly consisting of gram-negative rods with high rates of antibiotic resistance.

Sarah P Hammond and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae046, https://doi.org/10.1093/ofid/ofae046

Acyclovir-resistant mucocutaneous herpes simplex virus (HSV) infection is a rare morbid illness typically treated with foscarnet. In this multicenter retrospective study of foscarnet therapy, half of 31 HSV episodes resolved during or after therapy; renal and electrolyte-related adverse events were common.

Ellora N Karmarkar and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae029, https://doi.org/10.1093/ofid/ofae029

We interviewed 115 persons with mpox who did and did not receive tecovirimat, and performed a multivariable regression analysis. Initiating tecovirimat within 5 days of symptom onset appeared to be associated with faster improvement of symptoms in patients with severe mpox.

Dorothy E Loy and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae088, https://doi.org/10.1093/ofid/ofae088

Syringe access program (SAP) clients report high rates of hepatitis C virus (HCV) infection but limited access to treatment. They reported being more likely to get treated for HCV at the SAP and are comfortable with telemedicine-based appointments.

Philippa Randall and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae021, https://doi.org/10.1093/ofid/ofae021
Panpan Zhu and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae038, https://doi.org/10.1093/ofid/ofae038

We present the clinical characteristics, outcomes, and risk factors for coronavirus disease 2019 (COVID-19) in allogeneic hematopoietic stem cell transplantation recipients during the Omicron wave. The recipients exhibited a low COVID-19–related mortality rate and high moderate-to-severe and prolonged disease incidence.

Angela M Bengtson and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae093, https://doi.org/10.1093/ofid/ofae093
Phuti Sekwadi and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae118, https://doi.org/10.1093/ofid/ofae118

An increase in the number of enteric fever cases was observed in South Africa between 2020 and 2022. The outbreak predominantly affected illegal gold miners, likely due to the consumption of contaminated water while underground.

Jennifer Milucky and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae042, https://doi.org/10.1093/ofid/ofae042

Severe outcomes among pregnant women hospitalized with RSV infection were rare, and mild/asymptomatic infection was more frequently identified in pregnant women. In addition, more pregnant women delivered during their RSV-associated hospitalization during the COVID-19 pandemic vs before the pandemic.

Nick Petrucelli and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae130, https://doi.org/10.1093/ofid/ofae130

In this retrospective analysis, seizures and behavioral disturbances occurred following carbapenem administration in 46.3% and 50.8% of encounters, respectively, in patients with valproate exposure. Clinicians should be aware of this drug interaction and consider alternative antimicrobials when clinically appropriate.

Torgny Sunnerhagen and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae131, https://doi.org/10.1093/ofid/ofae131

Brief Reports

Jiaying Hao and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae086, https://doi.org/10.1093/ofid/ofae086
Miranda Monk and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae063, https://doi.org/10.1093/ofid/ofae063
Augustine O Ebonyi and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae092, https://doi.org/10.1093/ofid/ofae092
Alex N Zimmet and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae119, https://doi.org/10.1093/ofid/ofae119

Infection Prevention and Control

Major Articles

Jessica S Little and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae048, https://doi.org/10.1093/ofid/ofae048

We describe 5 health care–associated neuroinvasive Bacillus cereus infections. No point source was identified, and isolates were unrelated. Enhancing environmental cleaning, laundry management, and the neutropenic diet, as well as modifying empiric treatment protocols for febrile neutropenia, aborted the cluster.

Amanda M Graves and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae040, https://doi.org/10.1093/ofid/ofae040

We performed a prospective observational study to evaluate contamination of N95 respirators and face shields with SARS-CoV-2 when worn by healthcare providers giving care for SARS-CoV-2–positive patients housed in a COVID-19 unit. SARS-CoV-2 contamination was minimal.

Microbiology and Pathogenesis

Major Article

Zoe O Demko and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae027, https://doi.org/10.1093/ofid/ofae027

Thirty-three percent of unvaccinated adults with mild-to-moderate acute COVID-19 experienced long COVID symptoms; 8% still had not returned to their pre-COVID-19 health status 24 months postinfection. Long COVID symptoms peaked and quality of life nadired at 6–12 months postinfection.

Outbreak Investigations

Major Article

Maryam Soheilipour and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae032, https://doi.org/10.1093/ofid/ofae032

Hospitalization due to Shigella gastroenteritis can strikingly increase the 5-year risk of developing irritable bowel syndrome. Clinical and background factors, such as education level, abdominal cramps, and prolonged diarrhea during hospitalization, can affect this risk.

Tropical and Emerging Infectious Diseases

Major Article

G Ramírez-Olivencia and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae105, https://doi.org/10.1093/ofid/ofae105

The SEIMC-CEME-22 study in Spain investigated the mpox outbreak. Predominantly middle-aged, cisgender men with a high HIV prevalence were affected, primarily through sexual transmission. Prominent symptoms included rash (95.7%) and fever (48.2%). STI were concurrently diagnosed. Diverse treatments were administered.

Brief Report

Teagan King and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae101, https://doi.org/10.1093/ofid/ofae101

Vaccines and Immunization

Major Articles

Veronica Urdaneta and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae067, https://doi.org/10.1093/ofid/ofae067

This analysis evaluated observed-to-expected ratios for adverse events of special interest that were proposed in advance of COVID-19 vaccine use. Following administration of an estimated 772 908 958 doses of mRNA-1273, meaningful associations were found only for anaphylaxis, myocarditis, and pericarditis.

Yun Lu and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae051, https://doi.org/10.1093/ofid/ofae051

In a nationwide real-world study among nursing home residents, mRNA COVID-19 vaccines provided substantial protection against COVID-19–related death, even among prior COVID-19 survivors. Two-dose protection waned after 6 months. A third dose significantly boosted protection.

Novel ID Cases

Michael T Duong and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae110, https://doi.org/10.1093/ofid/ofae110

Perspectives

Vera P Luther and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae016, https://doi.org/10.1093/ofid/ofae016

Infectious Diseases (ID) Training Program Directors have observed an increase in clinical volume and acuity. Specific goals and strategies to manage the volume and acuity while preserving quality education in both the inpatient and ambulatory settings are described

Florence Momplaisir and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae083, https://doi.org/10.1093/ofid/ofae083

In this viewpoint, we discuss the consequences of the SCOTUS ruling ending race-conscious consideration for college admission, on diversifying the infectious disease workforce and combatting current and future pandemics. We provide strategies to mitigate this potential negative impact.

Christian B Ramers and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae080, https://doi.org/10.1093/ofid/ofae080

Letter to the Editor

Tobias Siegfried Kramer and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae075, https://doi.org/10.1093/ofid/ofae075

Correspondence

Heime Rieber
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae074, https://doi.org/10.1093/ofid/ofae074
Matthew R Davis and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae089, https://doi.org/10.1093/ofid/ofae089
Fionnuala Cox and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae109, https://doi.org/10.1093/ofid/ofae109
M Hong Nguyen and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae134, https://doi.org/10.1093/ofid/ofae134
Michael J Williams and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae135, https://doi.org/10.1093/ofid/ofae135

Corrections

Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae136, https://doi.org/10.1093/ofid/ofae136
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae145, https://doi.org/10.1093/ofid/ofae145
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae167, https://doi.org/10.1093/ofid/ofae167
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close